Fabtech Technologies Ltd

Fabtech Technologies Ltd Technicals

Fabtech Technologies Ltd Financials

Fabtech Technologies Ltd Shareholding Pattern

About Fabtech Technologies Ltd

Fabtech Technologies Limited was incorporated as a Private Company as 'Globeroute Ventures Private Limited' dated October 26, 2018 issued by the Registrar of Companies, Central Registration Centre. Subsequently, the name of the Company was changed to 'Fabtech Technologies Private Limited' vide fresh Certificate of Incorporation dated January 21, 2021. Further, the status was converted into a Public Company and renamed to 'Fabtech Technologies Limited', w.e.f. July 24, 2024, issued by the Central Processing Centre. The Company is a key turnkey engineering solution provider in pharmaceuticals capex space, offering comprehensive start to finish solutions encompassing designing, engineering, procurement, installation and testing of pharmaceutical equipment for a wide range of customers. In 2020, the Export Division of Fabtech Technologies International Private Limited (FTIPL), under which it executed turnkey pharmaceutical engineering projects, was demerged into the Company through Scheme of Amalgamation. Further, the entire shareholding also got transferred from FTIPL to shareholders of FTIPL, by virtue of which Aasif Ahsan Khan, Hemant Mohan Anavkar Aarif Ahsan Khan and Manisha Hemant Anavkar became the Promoters of the Company in 2020. The Company completed a a turnkey project for a state-owned organization in Bangladesh, involving installation of 172 clean room doors across designated buildings in 2022. It completed installation of process equipment, such as isolat ...ors, tablet compression equipment, and related infrastructure for a pharmaceutical manufacturer in Algeria in 2023. Further, completed procurement, implementation of facilities and monitoring of cleanrooms installation work for a facility to manufacture oral solid dosage, liquid oral dosage, disinfectant and penicillin secondary packaging area in Kingdom of Saudi Arabia. In 2024, the Company acquired FT Institutions Private Limited from FTIPL by executing turnkey pharmaceutical engineering projects in India. To create a local presence in the Middle Eastern region, it set up a wholly-owned subsidiary, Fabtech Technologies LLC and a step-down subsidiary, FTS Cleanrooms Systems LLC in Sharjah, UAE. The Company in 2024 has acquired FABL International Technologies LLP from FTIPL to consolidate its operations by developing manufacturing capabilities in oral solid dosage process solutions and further made acquisitions of a controlling stake of 51% in the erstwhile associate company, TSA Process Equipments Private Limited by Thermax Limited. The Step-Down Subsidiary, FTS Cleanrooms Systems LLC acquired the business undertakings and ongoing projects of FTS Lifecare Technical Services LLC through a Business Transfer Agreement in May, 2024. Company launched the initial public offer of 1,20,60,000 equity shares of Face Value of Rs 10 each by raising Rs 230.29 Cr through fresh issue in October 2025. The Company has acquired 33% stake in Mark Maker Engineering Private Limited, making it an associate of the Company in FY25.